Six versus nine cycles of paclitaxel-carboplatin as first-line chemotherapy in patients with newly diagnosed epithelial advanced ovarian cancer

Nayl, B.; Durando, Xavier; Pomel, Christophe; Dubray, P.; Mouret-Reynier, M-A; Bouëdec, G. Le; Gimbergues, Pierre; Chollet, P.; Dauplat, J; Curé, H.

doi:10.1200/jco.2009.27.15_suppl.e16535

Six versus nine cycles of paclitaxel-carboplatin as first-line chemotherapy in patients with newly diagnosed epithelial advanced ovarian cancer

NobleIDNI9P39W76R23S61

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DBFD5ABD.svg?ark=w1%2F20260521%2FDBFD5ABD&value=id)](https://nobleid.org/work/w1/20260521/DBFD5ABD)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Six versus nine cycles of paclitaxel-carboplatin as first-line chemotherapy in patients with newly diagnosed epithelial advanced ovarian cancer

NobleIDNI9P39W76R23S61

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DBFD5ABD.svg?ark=w1%2F20260521%2FDBFD5ABD&value=id)](https://nobleid.org/work/w1/20260521/DBFD5ABD)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work